The resolution designates the first full week of May each year as Tardive Dyskinesia Awareness Week in New Jersey. Tardive Dyskinesia (TD) is a serious neurological condition characterized by uncontrollable movements, often resulting from the use of dopamine receptor blocking agents (DRBAs), such as antipsychotics prescribed for mental health conditions like schizophrenia and bipolar disorder. With approximately 1.1 million adults in New Jersey living with mental illness, many of whom may be at risk for developing TD, the resolution emphasizes the need for increased awareness and regular screenings to facilitate early diagnosis and treatment.

The resolution highlights the significant stigma and barriers faced by individuals with TD, which can exacerbate their mental health challenges and lead to social withdrawal. It aims to promote understanding of TD's symptoms and the importance of timely medical intervention, as many affected individuals remain undiagnosed. By establishing Tardive Dyskinesia Awareness Week, the resolution seeks to encourage New Jerseyans to recognize the signs of TD and seek appropriate care, ultimately improving the quality of life for those impacted by this condition.